New York State Common Retirement Fund
COGT icon

New York State Common Retirement Fund’s Cogent Biosciences COGT Stock Holding History

New York State Common Retirement Fund’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67M Buy
224,116
+900
+0.4% +$31.5K 0.01% 846
2026
Q1 		$8.59M Buy
223,216
+178,814
+403% +$6.6M 0.01% 794
2025
Q4 		$1.58M Buy
44,402
+10,500
+31% +$295K ﹤0.01% 1499
2025
Q3 		$487K Buy
33,902
+10,800
+47% +$128K ﹤0.01% 1965
2025
Q2 		$166K Hold
23,102
– – ﹤0.01% 2343
2025
Q1 		$138K Hold
23,102
– – ﹤0.01% 2373
2024
Q4 		$180K Buy
23,102
+2,200
+11% +$21.9K ﹤0.01% 2347
2024
Q3 		$226K Sell
20,902
-9,000
-30% -$87.6K ﹤0.01% 2234
2024
Q2 		$252K Sell
29,902
-4,019
-12% -$30.5K ﹤0.01% 2330
2024
Q1 		$228K Buy
33,921
+13,360
+65% +$82.6K ﹤0.01% 2374
2023
Q4 		$121K Sell
20,561
-12,393
-38% -$95K ﹤0.01% 2672
2023
Q3 		$321K Buy
32,954
+10,770
+49% +$128K ﹤0.01% 2229
2023
Q2 		$263K Sell
22,184
-9,455
-30% -$108K ﹤0.01% 2378
2023
Q1 		$341K Sell
31,639
-14,426
-31% -$185K ﹤0.01% 2367
2022
Q4 		$533K Buy
46,065
+3,943
+9% +$48.9K ﹤0.01% 2282
2022
Q3 		$628K Buy
42,122
+16,667
+65% +$228K ﹤0.01% 2213
2022
Q2 		$230K Sell
25,455
-90
-0.4% -$614 ﹤0.01% 2734
2022
Q1 		$191K Buy
25,545
+39
+0.2% +$272 ﹤0.01% 2834
2021
Q4 		$219K Sell
25,506
-79
-0.3% -$687 ﹤0.01% 2838
2021
Q3 		$215K Sell
25,585
-6,215
-20% -$47.6K ﹤0.01% 2883
2021
Q2 		$258K Buy
+31,800
New +$269K ﹤0.01% 2930
2019
Q2 		– Sell
-125
Closed -$2K – 3255
2019
Q1 		$2K Hold
125
– – ﹤0.01% 3160
2018
Q4 		$2K Hold
125
– – ﹤0.01% 3183
2018
Q3 		$5K Hold
125
– – ﹤0.01% 3141
2018
Q2 		$7K Buy
+125
New +$6.01K ﹤0.01% 3166

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

New York State Common Retirement Fund's COGT Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Cogent Biosciences (COGT) stake by 0.4% in Q2 2026, buying an estimated $31.5K and bringing the position to 224,116 shares worth $8.67M. The position accounts for 0.01% of the portfolio, ranked #846.

New York State Common Retirement Fund first reported a position in COGT in Q2 2018 and has held it in 25 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • New York State Common Retirement Fund held 224,116 shares of Cogent Biosciences worth $8.67M as of Q2 2026.
  • New York State Common Retirement Fund bought 900 Cogent Biosciences shares in Q2 2026, an estimated $31.5K.
  • Cogent Biosciences made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #846 holding.
  • New York State Common Retirement Fund first reported a position in Cogent Biosciences in Q2 2018 and has held it in 25 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.